Latest filing published 10 Jun 2026 for Emergent BioSolutions Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Richard S. Lindahl is a declared insider at 3 companies (finance chief); the most frequent names are Emergent BioSolutions Inc., CEB Inc. and SPRINT Corp. Over a trading history stretching from 12 June 2006 to 8 June 2026, the count stands at 105 filings.
Both buying and selling appear: 2 purchases worth €131k, against 2 sales worth €692k. Taken together, the sales exceed the purchases by €561k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 72 share grants and 23 option exercises.
On 10 June 2026 came the latest disclosure, a share grant in Emergent BioSolutions Inc. The last insider purchase was made public on 15 November 2021, 1,804 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
23 of 23 declarations